These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 401427)

  • 1. Problems in measles and rubella.
    Horstmann DM
    Dis Mon; 1978 Mar; 24(6):1-52. PubMed ID: 401427
    [No Abstract]   [Full Text] [Related]  

  • 2. Present status of measles and rubella immunization in the United States: a medical progress report.
    Krugman S
    J Pediatr; 1977 Jan; 90(1):1-12. PubMed ID: 12253
    [No Abstract]   [Full Text] [Related]  

  • 3. Measles and rubella in Virginia: age shifts bring new problems.
    Hayden GF
    Va Med; 1983 Jun; 110(6):374-7. PubMed ID: 6880368
    [No Abstract]   [Full Text] [Related]  

  • 4. [Measles-rubella vaccination campaign].
    Infirm Fr; 1984 Jan; (251):23-6. PubMed ID: 6561159
    [No Abstract]   [Full Text] [Related]  

  • 5. [Measles. Elimination almost achieved!].
    Helwig H; Cremer H
    Kinderkrankenschwester; 2012 Jun; 31(6):234-7. PubMed ID: 22808669
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of measles and rubella through use of attenuated vaccines.
    Meyer HM; Hopps HE; Parkman PD; Ennis FA
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):128-35. PubMed ID: 685885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiologic study of measles, rubella and mumps with regard to the possibility of their control by immunization].
    Rodríguez Borrego MJ; García León J; Bolumar F; Nájera E
    Rev Sanid Hig Publica (Madr); 1985; 59(1-2):117-25. PubMed ID: 4059834
    [No Abstract]   [Full Text] [Related]  

  • 8. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity after rubella and measles viral vaccines.
    Dudgeon JA
    Am J Dis Child; 1978 Aug; 132(8):748-50. PubMed ID: 356586
    [No Abstract]   [Full Text] [Related]  

  • 10. The national measles and rubella campaign--one year on.
    Commun Dis Rep CDR Wkly; 1995 Nov; 5(45):237. PubMed ID: 8541943
    [No Abstract]   [Full Text] [Related]  

  • 11. [Indications for possibilities of preventive vaccination against measles and rubella].
    Siegert R
    Internist (Berl); 1971 Aug; 12(8):309-12. PubMed ID: 4936452
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunise Australia program: measles control campaign.
    Commun Dis Intell; 1998 Aug; 22(8):156. PubMed ID: 9735549
    [No Abstract]   [Full Text] [Related]  

  • 13. The 'new' epidemiology of measles and rubella.
    Cherry JD
    Hosp Pract; 1980 Jul; 15(7):49-57. PubMed ID: 7399493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles and rubella immunization. Statement of the Committe on Infectious Diseases, American Academy of Pediatrics.
    Postgrad Med; 1977 Jan; 61(1):269-72. PubMed ID: 834685
    [No Abstract]   [Full Text] [Related]  

  • 15. [Elimination of measles and rubella in Germany: Progress and hindrances].
    Pfaff G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1222-4. PubMed ID: 23990082
    [No Abstract]   [Full Text] [Related]  

  • 16. Measles and rubella in adolescents and young adults.
    Hinman AR
    Hosp Pract (Off Ed); 1982 Oct; 17(10):137-46. PubMed ID: 6811398
    [No Abstract]   [Full Text] [Related]  

  • 17. Measles-Rubella vaccination campaign: A trust deficit?
    Sreedevi A
    J Postgrad Med; 2018; 64(4):202-203. PubMed ID: 30306966
    [No Abstract]   [Full Text] [Related]  

  • 18. WHO European Region's strategy for elimination of measles and congenital rubella infection.
    Hanon FX; Spika John J; Wassilak Steven S; Emiroglu N
    Euro Surveill; 2003 Jun; 8(6):129-30. PubMed ID: 12878802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia.
    Carcelen AC; Mutembo S; Matakala KH; Chilumba I; Mulundu G; Monze M; Mwansa FD; Moss WJ; Hayford K
    Am J Trop Med Hyg; 2021 May; 104(6):2229-2232. PubMed ID: 33939639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.